Literature DB >> 6342920

Pulmonary hypertension. Anatomic and physiologic correlates.

B Meyrick, L Reid.   

Abstract

The types of pulmonary arterial hypertension described here all focus attention on the changes produced in the lung's microcirculation, particularly the precapillary unit. Although one senses intuitively that obliteration of resistance arteries is an effective cause of hypertension, we emphasize that cell metaplasia and adaptation by structural remodeling of the precapillary arterial wall is also effective in reducing the vascular bed. A question often asked is whether "pruning" is the cause of the hypertension . . . perhaps an inappropriate question. While the reduced cross-sectional area of the vascular bed is the basis for the rise in pulmonary vascular resistance and for its severity, the real question is what is the cause of the "pruning." Hypoxia, monocrotaline, and high flow each causes pulmonary artery hypertension--and pruning--but with differences in cell adaptation, timing, and severity that indicate different pathogenetic mechanisms and pathways. It is paradoxical that hypoxia, whose lesions are more reversible, produces a more severe hypertension and faster than the others. While the pathophysiologic aspects are important to clinical diagnosis and management, it is analysis of cause and pathways of pathogenesis that will give the keys to prevention and cure of the disease.

Entities:  

Mesh:

Year:  1983        PMID: 6342920

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  21 in total

Review 1.  5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.

Authors:  M R MacLean; P Herve; S Eddahibi; S Adnot
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function.

Authors:  Rebecca R Vanderpool; Ah Ram Kim; Robert Molthen; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2010-11-18

3.  Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction.

Authors:  Christa F Gaskill; Erica J Carrier; Jonathan A Kropski; Nathaniel C Bloodworth; Swapna Menon; Robert F Foronjy; M Mark Taketo; Charles C Hong; Eric D Austin; James D West; Anna L Means; James E Loyd; W David Merryman; Anna R Hemnes; Stijn De Langhe; Timothy S Blackwell; Dwight J Klemm; Susan M Majka
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

Review 4.  BMP signaling in vascular development and disease.

Authors:  Jonathan W Lowery; Mark P de Caestecker
Journal:  Cytokine Growth Factor Rev       Date:  2010-07-31       Impact factor: 7.638

5.  Continuous air embolization into sheep causes sustained pulmonary hypertension and increased pulmonary vasoreactivity.

Authors:  E A Perkett; K L Brigham; B Meyrick
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

6.  Utility of FVC/DLCO ratio to stratify the risk of mortality in unselected subjects with pulmonary hypertension.

Authors:  Lacedonia Donato; Carpagnano Giovanna Elisiana; Galgano Giuseppe; Schino Pietro; Correale Michele; Natale Daniele Brunetti; Ventura Valentina; Di Biase Matteo; Foschino Barbaro Maria Pia
Journal:  Intern Emerg Med       Date:  2016-11-25       Impact factor: 3.397

7.  Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension.

Authors:  E A Perkett; R M Lyons; H L Moses; K L Brigham; B Meyrick
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 8.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

9.  Morphometric analysis of the lung vasculature after extracorporeal membrane oxygenation treatment for pulmonary hypertension in newborns.

Authors:  Arno van Heijst; Remco Haasdijk; Freek Groenman; Frans van der Staak; Christina Hulsbergen-van de Kaa; Ronald de Krijger; Dick Tibboel
Journal:  Virchows Arch       Date:  2004-06-03       Impact factor: 4.064

10.  Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension.

Authors:  I Chazova; J E Loyd; V S Zhdanov; J H Newman; Y Belenkov; B Meyrick
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.